HOME / ABOUT US / COVID-19 TRAVERE THERAPEUTICS & COVID-19 November 16, 2020 As we face the uncertainties and challenges of a pandemic, Travere Therapeutics continues to come together as an organization in pursuit of our mission to identify, develop and deliver life-changing therapies to people living with rare disease. In fact, this mission has never been more important. Our work on behalf of patients continues because we have implemented proactive measures to best safeguard our employees. These measures include travel restrictions and a remote work environment. Like for so many during this time, that means hours on video conference calls, and juggling work with family and community responsibilities in profoundly new ways. As a team, we are proud of our work, of each other, and of ourselves because each of us knows that the purpose of our work is the patients we serve. We have taken steps to ensure patient access to our FDA-approved medications during the pandemic. The Total Care Hub is fully staffed and available to work with patients should they have product or shipping questions, need assistance with insurance verification, reimbursement options, or financial support. For those participating in our clinical trials, clinical investigators and study site staff – you are our critical partners in bringing potentially life-changing therapies to children and adults living with rare disease. We thank you. The safety of our clinical trial participants is paramount, and we continue to work closely with our principal investigators, participating physicians and individual sites to utilize best practices for keeping people safe in our studies all over the world. The Chronicle of Philanthropy reports that 22,000 nonprofits in the US will fail due to the pandemic. Nonprofit voluntary health organizations are the lifeblood of many rare disease patients and caregivers, providing services, equipment, educational resources and community. We established a COVID Emergency Assistance Fund for nonprofit patient advocacy organizations to continue to operate and support these communities, and we are helping to form bridges between these nonprofit organizations to learn from one another and push forward in their work. We know that rare diseases do not wait for pandemics like coronavirus, and our organization remains steadfast in its dedication to serving our patients and caregivers. We wish you, your organization and community well. © 2021 Travere Therapeutics, Inc. All rights reserved. For US audiences. Chenodal®, Cholbam® and Total Care HUB® are registered trademarks of Travere Therapeutics, Inc. Thiola® and Thiola EC® are registered trademarks of Mission Pharmacal Company. Terms and Conditions | Privacy Policies | Cookie Preferences This website uses cookies for optimal site functionality. By continuing to use this website, you consent to our use of cookies. To change your cookie preferences, click on "Cookie Settings" or for more information, please see ourPrivacy Policies. Accept All Cookies Cookie Settings